Dr. Carmen Martinez  Chamorro

Dr. Carmen Martinez Chamorro

Address: Hospital Universitario Quirónsalud Madrid c/ Diego de Velázquez, 1 28223 Pozuelo de Alarcón Madrid, Madrid, Madrid, Comunidad de, 28223, Spain

Gender: Female

Type of Professional: Hematologist

Associated Healthcare Provider: Hospital Universitario Quirónsalud Madrid

Languages Spoken: Spanish

About the Doctor / Professional

Dr. Carmen Martínez Chamorro is the Associate Head of the Hematology and Hemotherapy Service of Hospital Universitario Quirónsalud Madrid and CAR-T Therapy Coordinator.

She has a degree in Medicine and Surgery from the Faculty of Medicine of the University of Valladolid with Extraordinary Degree Award and Third National Prize for Completion of Medicine and Surgery Studies. She completed her training as a Specialist in Hematology and Hemotherapy at the University Hospital of La Princesa in Madrid, under the direction of Dr. Fernández-Rañada. She was responsible for the Clinical Hematology and Hematopoietic Transplantation Unit of the Rúber Clinic in Madrid from February 1997 to 2007. She is currently incharge of the Clinical Hematology and Hematopoietic Transplantation Service of the Quirónsalud Madrid University Hospital.

Dr. Carmen is a Patron of the Leukemia and Lymphoma Foundation since its foundation and has also been an evaluator of the Marcos Fernández Research Grants in the area of Leukemia, Lymphoma and Myeloma on different occasions.

She has also authored more than 20 articles published in international and national journals, more than 60 communications in international and national congresses and 10 book chapters. She has also been a speaker at meetings and congresses of the specialty on different occasions.

Dr. Carmen has participated as a Researcher in more than 15 clinical trials, 9 of them as Principal Investigator. She is a member of the Clinical Trials Committee of the University Hospital of Quirónsalud Madrid. Her areas of special interest are:

  • Onchohematological neoplasms (leukemia, lymphoma and myeloma)
  • Hematopoietic transplantation
  • CAR-T cell therapy